Established & Proven

More than 24-years of deep clinical research management experience

Avance Clinical has more than 24 years of deep clinical experience delivering high-quality trial data that is accepted by all of the major regulatory agencies around the globe.

Approximately 96% of the work is supporting small to medium-sized biotechnology companies executing Phase 1 and Phase 2 trials. Avance Clinical’s client base currently extends across APAC, North America, Canada, EU, and New Zealand.

View Our Experience

Cardiovascular

Atrial fibrillation, hypertension, hypertrophic cardiomyopathy, peripheral artery disease

CNS

Alzheimer’s, amyotrophic lateral sclerosis, anxiety, autism, Duchenne muscular dystrophy, fragile X, Huntington’s disease, major depressive disease (MDD), meningitis, multiple sclerosis, myasthenia gravis, Parkinson’s disease, recovery after stroke, schizophrenia, treatment-resistant depression

Dermatology

Acne vulgaris, actinic keratosis, age-related macular degeneration, alopecia areata, atopic dermatitis, erythropoietic protoporphyria (EEP),  inflammatory skin diseases, polymorphous light eruption (PLE), psoriasis, solar urticaria

Sexual Disfunction & Disorders

Erectile Dysfunction

Haematology

Anaemia, iron deficiency anaemia

Infectious Diseases

COVID-19, hepatitis B, hepatitis C, human immunodeficiency virus, malaria, respiratory syncytial virus, severe bacterial infection

Metabolism & Nutritional Disorders

Acromegaly, alpha-1 antitrypsin deficiency (AATD), cystic fibrosis, Fabry disease, hypoandrogenism, rheumatoid arthritis, type I diabetes, type II diabetes

Musculoskeletal & Connective Tissue Disorders

Anti-fibrotic and anti-inflammatory, cervical dystonia, lumbosacral radiculopathy, muscle spasms, postmenopausal osteoporosis

Oncology

Haematological malignancies (including B-cell lymphoid, multiple myeloma), solid tumours (including renal, breast, colorectal, glioblastoma multiforma, ovarian, allcomers)

Ophthalmology

Glaucoma, macular degeneration

Otorhinolaryngology (ENT)

Eustachain tube dysfunction, otitis media with effusion

Paediatric/Neonatology

Preterm infants

Pain

Burns patients, chronic pain, neuropathic pain, non steroidal/non opioid analgesic, osteoarthritis, postherpetic neuralgia, sciatica

Respiratory, Allergy, Thoracic & Mediastinal Disorders

Asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), cystic fibrosis, non-CF bronchiectasis

Urology

Overactive bladder

Full Service CRO

With more than 150 CRO specialist experts in-house your study is in the best hands for success.

The latest technology for data compliance

Avance Clinical has a Medidata accredited team in-house along with experts trained in the other leading technology tools including Medrio and Oracle.

The Australian Government R&D grant means up to 43.5% rebate on clinical trial spend
Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks
Globally accepted data
No IND required for clinical trials

Request a Proposal or Talk to our Team  CONTACT US

More benefits

Avance Clinical can leverage all the benefits of Australia and New Zealand’s clinical ecosystem to deliver your study

Almost half clinical costs

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Rapid Start-up

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

Start-up time

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

No IND

No IND required for clinical trials

GMP material

Full GMP material is not mandated for Phase I clinical trials

Gene-therapy accreditation

Avance Clinical is an accredited gene-therapy CRO

Seasonal studies

Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia and New Zealand's counter-flu and allergy seasons

FDA and global regulatory data compliance

Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track record in FDA compliant research

Rebate

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Start-up time

Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks

Capabilities

Full service CRO in Australia and New Zealand

An Experienced Team

Learn more about us here

195
Studies in the past 5 years
150
Experienced Team Members
10,000
Participants in the past 5 years
24
Years of experience

Ready To Partner with Us?

Contact Us